How saliva metabolites change in pregnancy and gum disease
Official title: Salivary Metabolomics of Pregnancy and Periodontal Disease Related Metabolic Pathways
Run by Bezmialem Vakif University · NCT07054177 · Data updated 2026-11-12
This project will test whether saliva metabolites change across pregnancy and after birth by comparing pregnant people to non‑pregnant volunteers to learn how hormonal shifts relate to gum inflammation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Bezmialem Vakif University Academic / other |
| Locations | 1 site (Istanbul, Fatih) |
| Status | Recruiting |
| Started | June 24, 2025 |
| Main results expected | March 2026 |
| Study ends | April 2026 |
| Registry record updated | July 23, 2025 |
| Trial ID | NCT07054177 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy pregnant people aged 18–40 with a singleton, uncomplicated pregnancy and non‑pregnant healthy volunteers who meet the listed inclusion criteria.
✕Probably not a fit
People with systemic disease, BMI over 30, recent antibiotic or anti‑inflammatory use, smoking or alcohol use, or complicated pregnancies are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect saliva samples from 15 pregnant volunteers in the 1st, 2nd, and 3rd trimesters and again 6–8 weeks after delivery, plus samples from a matched group of non‑pregnant healthy controls. Clinical periodontal status will be recorded alongside sample collection to link metabolic signals with gum health. Samples will be analyzed using untargeted LC‑MS/MS metabolomics to identify metabolites and pathways associated with pregnancy‑related hormonal changes and periodontal changes. The study is single‑center and longitudinal but relatively small, intended to generate hypotheses and candidate biomarkers for further work.
Why it matters
Potential benefit: If successful, the work could identify saliva markers that help explain or predict pregnancy gingivitis and guide targeted prevention or monitoring.
How similar studies have gone: Previous research has shown pregnancy alters oral microbiota and some saliva biomarkers, but untargeted saliva metabolomics in this specific pregnancy–periodontal context is relatively exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 40 years * No history of systemic disease or chronic infection * No use of antibiotics or anti-inflammatory drugs in the last 3 months * Non-smoker and non-alcohol user * Willingness to participate by signing the informed consent form Additional Criteria for Pregnant Volunteers: * Singleton pregnancy (no multiple gestation) * Pregnancy progressing without complications (e.g., no diagnosis of preeclampsia, gestational diabetes, or threatened preterm labor) * Gestational age confirmed by ultrasound Additional Criteria for Non-Pregnant Control Group: * No history of pregnancy in the past 6 months * Regular menstrual cycles * No history of hormonal disorders (e.g., polycystic ovary syndrome, thyroid dysfunction) Exclusion Criteria: * Use of anti-inflammatory or antimicrobial treatments in the past 3 months * Smoking or alcohol consumption * Body mass index (BMI) \> 30 kg/m² * Presence of systemic diseases including diabetes mellitus, hyperprolactinemia, congenital adrenal hyperplasia, androgen-secreting tumors, thyroid dysfunction, Cushing's syndrome, hypertension, liver or kidney dysfunction * Use of medications that may affect metabolic or hormonal parameters, such as oral contraceptives, steroid hormones, antihypertensives, or insulin-sensitizing drugs * Periodontal treatment in the past 6 months * Use of medications known to affect periodontal status (e.g., phenytoin, calcium channel blockers, cyclosporine, warfarin, NSAIDs, aspirin \> 81 mg) * Active infectious diseases such as hepatitis, HIV, or tuberculosis
Where it's running
-
Bezmialem Vakıf University, Faculty of Dentistry and Faculty of Medicine, Istanbul
Istanbul, Fatih, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Cansu Can Yasar, Periodontist
- Email: cansu.ysr@gmail.com
- Phone: +905453153495
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Alpha-Lipoic Acid as an Adjunct to Non-Surgical Periodontal Treatment for Gingivitis
This study tests whether adding alpha-lipoic acid to standard non-surgical gum treatment can help people with gingivitis see improved biomarkers and symptoms.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.